Paul Hudson (businessman)
Paul Hudson | |
|---|---|
 Hudson in 2023 | |
| Born | 14 October 1967[1] |
| Education | Manchester Metropolitan University |
| Title | Former CEO, Sanofi |
| Term | September 2019 – February 2026 |
| Predecessor | Olivier Brandicourt |
| Successor | Belén Garijo |
| Children | 3 |
Paul Hudson (born 14 October 1967)[2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[3]
Early life
Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[1]
Career
Hudson was CEO of Sanofi since September 2019. In February 2026, it was announced Hudson’s mandate would not be renewed and he will step down as CEO.[4][5][6]
Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America.[6][7][8]
Recognition
Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1][9]
Personal life
Hudson has three children and is an "ardent Manchester United football fan".[1]
References
- 1 2 3 4 "Paul Hudson - Sanofi". www.sanofi.com. Archived from the original on 3 February 2021. Retrieved 26 January 2021.
- ↑ "Paul Hudson - Sanofi". www.sanofi.com. Archived from the original on 28 February 2021. Retrieved 29 January 2021.
- ↑ Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine". Archived from the original on 17 May 2021. Retrieved 26 January 2021 – via www.theguardian.com.
- ↑ "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune. Archived from the original on 3 February 2021. Retrieved 26 January 2021.
- ↑ "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020. Archived from the original on 26 March 2021. Retrieved 26 January 2021.
- 1 2 "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates. Archived from the original on 24 February 2021. Retrieved 26 January 2021.
- ↑ "AstraZeneca announces changes to Senior Executive Team". Fiercepharma. Archived from the original on 24 April 2023. Retrieved 24 April 2023.
- ↑ "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis". Novartis. Archived from the original on 24 April 2023. Retrieved 24 April 2023.
- ↑ "Paul Hudson". Manchester Metropolitan University. Retrieved 24 April 2023.